| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,465,000 | 1,312,000 | 1,194,000 | 1,261,000 | | Cost of Revenue | (2,175,000) | 1,180,000 | 995,000 | 1,113,000 | | | Gross Profit | 3,640,000 | 132,000 | 199,000 | 148,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,389,000 | 134,000 | 133,000 | 142,000 | | Non Recurring | 1,000 | 7,000 | 7,000 | 341,000 | | Others | 1,130,000 | 23,000 | 22,000 | 26,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,000 | (32,000) | 37,000 | (361,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,000 | (32,000) | 37,000 | (361,000) | | Interest Expense | (77,000) | (30,000) | 107,000 | (197,000) | | Income Before Tax | 83,000 | (2,000) | (70,000) | (164,000) | | Income Tax Expense | 26,000 | 4,000 | (21,000) | (43,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 57,000 | (6,000) | (49,000) | (121,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 57,000 | (6,000) | (49,000) | (121,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $57,000 | ($6,000) | ($49,000) | ($121,000) |
|
1.48% Nasdaq 
Income Statement
